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We report the ﬁrst case of a pancreatic desmoid tumor detected during follow-up for hemihypertrophy
in a 4-year-old boy. Hemihypertrophy is a rare disorder in which one side of the body grows more than
the other, causing asymmetry, and well-known complications include embryonal tumors. However,
there has been no report of desmoid tumors in patients with hemihypertrophy, and these tumors are rare
and poorly characterized in the literature, especially the cystic variant. For this patient, the lesion was
diagnosed as a desmoid tumor based on immunostaining positive for beta-catenin and mutation of the
beta-catenin gene (CTNNB1). This case suggests that desmoid tumors should be considered a possible
etiology of pancreatic cystic lesions in patients with hemihypertrophy.
 2015 The Authors. Published by Elsevier Inc. This is an open access article under the CC BY-NC-ND
license (http://creativecommons.org/licenses/by-nc-nd/4.0/).Hemihypertrophy, also called hemihyperplasia, is a rare disorder
in which one side of the body grows more than the other, causing
asymmetry [1]. The incidence of hemihypertrophy is reported to be
1 in every 13,200 to 86,000 births [2,3], and well-known compli-
cations are kidney malformation, cryptorchidism, and embryonal
tumors. The overall incidence of embryonal tumors in patients with
hemihypertrophy is 5.9%, and Hoyme et al. found that, amongst 168
children with isolated hemihyperplasia who were followed for 10
years, there were 6 Wilms tumors, 1 hepatoblastoma, 2 adrenal cell
carcinomas, and 1 small bowel leiomyosarcoma [4].
Desmoid tumors, or musculoaponeurotic ﬁbromatoses, are
non-metastatic, locally aggressive neoplasms with a high rate of
postoperative recurrence, and represent approximately 0.03% of all
tumors and 3% of soft tissue tumors [5]. Pancreatic desmoid tumors
are exceedingly rare, and only a few cases have been reported to
date [6]. There has been no report of desmoid tumors in patients
with hemihypertrophy., National Center for Child
ku, Tokyo 157-8535, Japan.
Inc. This is an open access article u1. Case report
A 4-year-old boywith hemihypertrophywas undergoing routine
follow-up with periodical ultrasonography (US). The child was born
normally after 39 weeks of gestation at another hospital. Two
months after birth it was noted that his feet were of different
lengths, and he was diagnosed with hemihypertrophy. There was
no remarkable family history. The patient was referred to our
department at the age of 1 year and was being followed up with
semiannual US. At the age of 4 years, US revealed an asymptomatic
cystic lesion in the left upper quadrant of the abdomen (Fig. 1a and
b). The mass was located in the tail of the pancreas. Abdominal
computed tomography (CT) showed a low density mass (Fig. 2a)
and magnetic resonance imaging (MRI) showed a low intensity
mass in a T1-weighted image (WI) and a high signal mass in a T2-
WI (Fig. 2b and c). There was no signal abnormality on diffusion WI
and the apparent diffusion coefﬁcient (ADC) value was
3.26  103 mm2/s, which indicated a non-malignant pattern. No
distant metastasis was detected. Laboratory analysis including tu-
mor markers showed values within the normal range (carcinoem-
bryonic antigen, 0.6 ng/mL; alpha-fetoprotein, 2.7 ng/mL; and
carbohydrate antigen 19-9, 12.1 U/mL).nder the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).
Fig. 1. (a and b) Ultrasonography (US) showing a cystic mass in the abdomen. The mass was located in the tail of the pancreas and contained a cystic component with multiple
septation and a minimal solid component.
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differential diagnosis included lymphangioma, solid pseudopapil-
lary neoplasm, malignant pancreatic tumor (pancreaticoblastoma),
and mucinous cystadenoma. The lesion was surgically resected by
distal pancreatectomy. The resected specimen measured
4.5  3.0  2.5 cm. On the cut surface, a white solid lesion with
multilocular cysts was seen in the pancreas (Fig. 3a). The lesionwas
well demarcated from the pancreas and had invaded the stomach
wall. Histologically, the tumor was composed of proliferating
spindle cells with ﬁne cytoplasm. The cyst walls were covered with
a low columnar epithelium mimicking the dilated pancreatic duct
(Fig. 3b). Immunohistochemical analysis revealed that these spindle
cells were partially positive for vimentin, B-cell lymphoma 2, alpha
smooth muscle actin, and Muscle actin antibody (HHF35), and the
nuclei of the spindle cells were positive for beta-catenin (Fig. 3c).Fig. 2. (a) A plain abdominal computed tomography image revealed a low-density area at
weighted image (WI). (b) Magnetic resonance imaging (MRI) showed mainly cystic masses
showing a high intensity mass.The spindle cells were negative for S-100 protein, CD34, CD117, and
pan keratin AE1/3. The MIB1 labeling index was less than 1%. A
mutation in exon 3 of the beta-catenin gene (CTNNB1) was detec-
ted, and was predicted to encode the 41A CTNNB1 protein. Based on
these histological ﬁndings and the CTNNB1mutation, we diagnosed
the lesion as a desmoid tumor. The postoperative course was un-
eventful, and no recurrence has been detected 3 years after surgery.
2. Discussion
To the best of our knowledge, this is the ﬁrst report of a
pancreatic desmoid tumor in a patient with hemihypertrophy.
Intra-abdominal desmoid tumors have been occasionally reported,
although desmoid tumors in the pancreas are exceptionally rare
with only 11 reported cases [6]. Abdominal desmoid tumors arethe pancreatic tail without obvious calciﬁcation and a high intensity signal on a T2-
that originated from the pancreatic tail with low signal intensity on T1-WI. (c) T2-WI
Fig. 3. (a) Cut surface of the pancreatic tumor. The solid, white tumor was well separate from the pancreas. Cystic lesions were present inside the tumor. (b) Histologically, the tumor
was composed of proliferating spindle cells with ﬁne cytoplasm. The tumor diffusely expanded into the pancreas. The cyst wall was lined with low columnar epithelium resembling
a pancreatic duct (Hematoxylin and eosin stain. 20). (c) Immunohistochemical analysis revealed that the spindle cell nuclei were positive for beta-catenin (40).
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incidence in the third decade, and are rare in patients younger than
10 years old [7]. A pancreatic desmoid tumor in a 4-year-old boy is
thus highly atypical, and the pancreas is a very rare site for desmoid
tumors, especially in children [6].
Desmoid tumors, also known as musculoaponeurotic ﬁbroma-
toses, are locally aggressive soft tissue neoplasms that are histo-
logically characterized by ﬁbroblastic proliferation within a
collagen matrix. Three CTNNB1 gene variants (41A, 45F, and 45P)
are known to be speciﬁc for sporadic desmoid tumors [8], and the
tumor in the present case was positive for b-catenin and harbored a
41A CTNNB1 gene mutation. However, at initial presentation, a
pancreatic epidermoid cyst or lymphangioma was suspected, and a
desmoid tumor was not considered. Desmoid tumors do not usually
show cystic features, and their appearance depends on the relative
degree of ﬁbroblast proliferation, ﬁbrosis, collagen content, and
vascularity. Although some studies have reported CT or MRI ﬁnd-
ings for these tumors [9,10], they have no speciﬁc imaging features,
and it is therefore difﬁcult to distinguish desmoid tumors from
other solid masses [11]. Most cystic lesions of the pancreas are
benign and the most frequent pancreatic cystic lesion is a pancre-
atic pseudocyst, accounting for 70e90% of such lesions, while pri-
mary cystic neoplasms account for 10e15% of cases [12].
The underlying etiology for desmoid tumor development is
probably multifactorial. Hemihypertrophy may be associated with
the development of the pancreatic desmoid tumor in the present
case. However, hemihypertrophy is diagnosed only on the basis of
clinical manifestations, and consequently includes various diseases
such as Beckwith-Wiedemann syndrome and familial adenomatouspolyposis. The tumor in our case may have had a different etiology
from those in other patients with hemihypertrophy.
3. Conclusion
Although preoperative diagnosis is difﬁcult, desmoid tumors
should be included in the differential diagnosis if there are
pancreatic cystic ﬁndings. Mutational analysis should be performed
to identify CTNNB1 gene mutations, which has both diagnostic and
prognostic relevance. This case highlights the need to consider
desmoid tumors as a possible etiology of pancreatic cystic lesions in
patients with hemihypertrophy.
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